ABILIFY (aripiprazole) Otsuka Patent: 8,518,421 Expiration: Jul 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of July 18, 2021 Read Post »
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are eight…
The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on Dr…
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER (esmolol hydrochloride) Baxter hlthcare Patent: 6,310,094 Expiration: Jul 12, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of July 11, 2021 Read Post »
Annual Drug Patent Expirations for BREVIBLOC+IN+PLASTIC+CONTAINER Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three suppliers. There…
The post New patent expiration for Baxter Hl…
New patent expiration for Baxter Hlthcare drug BREVIBLOC IN PLASTIC CONTAINER Read Post »
Annual Drug Patent Expirations for BREVIBLOC Brevibloc is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three suppliers. There are two patents…
The post New patent expiration for Baxter Hlthcare drug BREVIBLOC appe…
New patent expiration for Baxter Hlthcare drug BREVIBLOC Read Post »
Annual Drug Patent Expirations for BREVIBLOC+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Brevibloc Double Strength In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three…
The post New patent expiratio…
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Allergan drug ALPHAGAN P appeared first …
New patent expiration for Allergan drug ALPHAGAN P Read Post »
Annual Drug Patent Expirations for RESCULA Rescula is a drug marketed by Sucampo Pharma Llc and is included in one NDA. There is one patent protecting this drug and one…
The post New patent expiration for Sucampo Pharma drug RESCULA appeared first on D…
New patent expiration for Sucampo Pharma drug RESCULA Read Post »
Annual Drug Patent Expirations for FASLODEX Faslodex is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Astrazeneca drug FASLODEX appear…
New patent expiration for Astrazeneca drug FASLODEX Read Post »
Annual Drug Patent Expirations for XENLETA Xenleta is a drug marketed by Nabriva and is included in two NDAs. There are four patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Nabriva drug XENLETA appeared firs…